Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

N-Cadherin Stabilizes β-Catenin and Promotes β-Catenin/TCF Transcriptional Activation and Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma

Shiqiao Ye, Yu Chen, Bo Hu, Huayu Huang, Yuxiao Sun, James P Stewart, Sarah K Johnson, Bart Barlogie, Maurizio Zangari, Guido Tricot, Faith E Davies, Gareth J Morgan, Brian A Walker, Fenghuang Zhan, Frits van Rhee, John D Shaughnessy, Jr., Ya-Wei Qiang

Blood (2021) 138 (Supplement 1): 1572.

https://doi.org/10.1182/blood-2021-148624

Published: 2021

Journal Articles

CYR61 /CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease

Sarah K. Johnson, James P. Stewart, Rakesh Bam, Pingping Qu, Bart Barlogie, Frits van Rhee, John D. Shaughnessy, Jr, Joshua Epstein, Shmuel Yaccoby

Blood (2014) 124 (13): 2051–2060.

https://doi.org/10.1182/blood-2014-02-555813

Published: 2014

Includes: Supplemental data

Journal Articles

CKS1B , overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27 Kip1 -dependent and -independent mechanisms

Fenghuang Zhan, Simona Colla, Xiaosong Wu, Bangzheng Chen, James P. Stewart, W. Michael Kuehl, Bart Barlogie, John D. Shaughnessy, Jr

Blood (2007) 109 (11): 4995–5001.

https://doi.org/10.1182/blood-2006-07-038703

Published: 2007

Journal Articles

A Validated Gene Expression Signature of High Risk Multiple Myeloma Is Defined by Deregulated Expression of Genes Mapping to Chromosome 1.

John D. Shaughnessy, Jr., Fenghuang Zhan, Bart Burington, Yongsheng Huang, Ichiro Hanamura, James P. Stewart, Klaus Hollmig, Mauricio Pineda-Roman, Guido Tricot, Frits van Rhee, Maurizio Zangari, John Crowley, Bart Barlogie

Blood (2006) 108 (11): 111.

https://doi.org/10.1182/blood.V108.11.111.111

Published: 2006

Journal Articles

CKS1B, Mapping to an Amplicon on Chromosome 1q21 and over Expressed in Aggressive Disease, Regulates Multiple Myeloma Growth and Survival through p27 Kip1 -Dependent and Independent Mechanisms.

Fenghuang Zhan, Simona Colla, James B. Chen, James P. Stewart, Xiaosong Wu, Yongsheng Huang, Ichiro Hanamura, Bart Burington, Shmuel Yaccoby, Joshua Epstein, Bart Barlogie, John D. Shaughnessy, Jr.

Blood (2006) 108 (11): 3408.

https://doi.org/10.1182/blood.V108.11.3408.3408

Published: 2006

Journal Articles

Testing Standard and Genetic Markers in 220 Patients with Multiple Myeloma (MM) with Complete Data Sets: Superiority of Molecular Genetics.

John D. Shaughnessy, Jr., Jeffrey Haessler, Ichiro Hanamura, Yongsheng Huang, James P. Stewart, Fenghuang Zhan, Jeffrey Sawyer, Elias Anaissie, Frits van Rhee, Guido Tricot, Joshua Epstein, Maurizio Zangari, Mauricio Pineda-Roman, Klaus Hollmig, John Crowley, Bart Barlogie

Blood (2006) 108 (11): 3391.

https://doi.org/10.1182/blood.V108.11.3391.3391

Published: 2006

Journal Articles

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

Blood (2006) 109 (6): 2276–2284.

https://doi.org/10.1182/blood-2006-07-038430

Published: 2006

Journal Articles

The molecular classification of multiple myeloma

Blood (2006) 108 (6): 2020–2028.

https://doi.org/10.1182/blood-2005-11-013458

Published: 2006

Includes: Supplemental data

Journal Articles

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation

Ichiro Hanamura, James P. Stewart, Yongsheng Huang, Fenghuang Zhan, Madhumita Santra, Jeffrey R. Sawyer, Klaus Hollmig, Maurizio Zangarri, Mauricio Pineda-Roman, Frits van Rhee, Federica Cavallo, Bart Burington, John Crowley, Guido Tricot, Bart Barlogie, John D. Shaughnessy, Jr

Blood (2006) 108 (5): 1724–1732.

https://doi.org/10.1182/blood-2006-03-009910

Published: 2006

Includes: Supplemental data

Journal Articles

Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

Blood (1997) 89 (8): 3055–3060.

https://doi.org/10.1182/blood.V89.8.3055

Published: 1997

Journal Articles

Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia [letter]

R Storb, P Martin, HJ Deeg, JE Sanders, M Pepe, J Singer, C Anasetti, P Stewart, FR Appelbaum, KM Sullivan

Blood (1992) 79 (11): 3091–3092.

https://doi.org/10.1182/blood.V79.11.3091.3091

Published: 1992

Journal Articles

What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?

R Storb, M Pepe, C Anasetti, FR Appelbaum, P Beatty, K Doney, P Martin, P Stewart, KM Sullivan, R Witherspoon

Blood (1990) 76 (5): 1037–1045.

https://doi.org/10.1182/blood.V76.5.1037.1037

Published: 1990

Journal Articles

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

PJ Martin, JA Hansen, CD Buckner, JE Sanders, HJ Deeg, P Stewart, FR Appelbaum, R Clift, A Fefer, RP Witherspoon

Blood (1985) 66 (3): 664–672.

https://doi.org/10.1182/blood.V66.3.664.664

Published: 1985

Journal Articles

Marrow harvesting from normal donors

CD Buckner, RA Clift, JE Sanders, P Stewart, WI Bensinger, KC Doney, KM Sullivan, RP Witherspoon, HJ Deeg, FR Appelbaum

Blood (1984) 64 (3): 630–634.

https://doi.org/10.1182/blood.V64.3.630.630

Published: 1984

Journal Articles

Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse

FR Appelbaum, RA Clift, CD Buckner, P Stewart, R Storb, KM Sullivan, ED Thomas

Blood (1983) 61 (5): 949–953.

https://doi.org/10.1182/blood.V61.5.949.949

Published: 1983

Journal Articles

Fanconi's anemia treated by allogeneic marrow transplantation

HJ Deeg, R Storb, ED Thomas, F Appelbaum, CD Buckner, RA Clift, K Doney, L Johnson, JE Sanders, P Stewart, KM Sullivan, RP Witherspoon

Blood (1983) 61 (5): 954–959.

https://doi.org/10.1182/blood.V61.5.954.954

Published: 1983

Journal Articles

Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

R Storb, RL Prentice, M Banaji, RP Witherspoon, KM Sullivan, P Stewart, JE Sanders, M Mason, K Doney, J Deeg, RA Clift, CD Buckner, FR Appelbaum, ED Thomas

Blood (1983) 61 (4): 672–675.

https://doi.org/10.1182/blood.V61.4.672.672

Published: 1983

NARROW

N-Cadherin Stabilizes β-Catenin and Promotes β-Catenin/TCF Transcriptional Activation and Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma

CYR61 /CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease

CKS1B , overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27 Kip1 -dependent and -independent mechanisms

A Validated Gene Expression Signature of High Risk Multiple Myeloma Is Defined by Deregulated Expression of Genes Mapping to Chromosome 1.

CKS1B, Mapping to an Amplicon on Chromosome 1q21 and over Expressed in Aggressive Disease, Regulates Multiple Myeloma Growth and Survival through p27 Kip1 -Dependent and Independent Mechanisms.

Testing Standard and Genetic Markers in 220 Patients with Multiple Myeloma (MM) with Complete Data Sets: Superiority of Molecular Genetics.

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

The molecular classification of multiple myeloma

Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation

Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia [letter]

What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

Marrow harvesting from normal donors

Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse

Fanconi's anemia treated by allogeneic marrow transplantation

Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only